לבטיראצטם טבע ® 1000 מ"ג

Country: Iżrael

Lingwa: Ebrajk

Sors: Ministry of Health

Ingredjent attiv:

LEVETIRACETAM 1000 MG

Disponibbli minn:

TEVA PHARMACEUTICAL INDUST.LTD

Kodiċi ATC:

N03AX14

Għamla farmaċewtika:

TABLETS

Rotta amministrattiva:

PER OS

Manifatturat minn:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Grupp terapewtiku:

LEVETIRACETAM

Indikazzjonijiet terapewtiċi:

- Levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - Levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.- Levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- Levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

Data ta 'l-awtorizzazzjoni:

2009-09-01